METTL16 ‐mediated N6 ‐methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer
Cell Proliferation · 2024
DOI: 10.1111/cpr.13590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2024. Verfasst von Jimin Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Affiliated Anhui Provincial Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Adenosine, Chromosomal Instability, Chromosome Segregation, Colorectal Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Anhui Province, Scientific Research Project of Anhui Provincial Education Department.
Abstract (Originalsprache)
N6‐methyladenosine (m6A) is the most prevalent internal modification in mammalian messenger RNAs and is associated with numerous biological processes. However, its role in chromosomal instability remains to be established. Here, we report that an RNA m6A methyltransferase, METTL16, plays an indispensable role in the progression of chromosome segregation and is required to preserve chromosome stability in colorectal cancer (CRC) cells. Depletion or inhibition of the methyltransferase activity of METTL16 results in abnormal kinetochore‐microtubule attachment during mitosis, leading to delayed mitosis, lagging chromosomes, chromosome mis‐segregation and chromosomal instability. Mechanistically, METTL16 exerts its oncogenic effects by enhancing the expression of suppressor of glucose by autophagy 1 ( Soga1 ) in an m6A‐dependent manner. CDK1 phosphorylates Soga1, thereby triggering its direct interaction with the polo box domain of PLK1. This interaction facilitates PLK1 activation and promotes mitotic progression. Therefore, targeting the METTL16‐Soga1 pathway may provide a potential treatment strategy against CRC because of its essential role in maintaining chromosomal stability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Affiliated Anhui Provincial Hospital of Anhui Medical University, Hefei, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China.
- Graduate School, Bengbu Medical College, Bengbu, China.
- School of Pharmacy, Anhui Medical University, Hefei, China.
- Department of Hepatobiliary Surgery, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology o…
ORCID-Profile: Hao Wang
Förderung
- Natural Science Foundation of Anhui Province
- Scientific Research Project of Anhui Provincial Education Department
Zitieren
APA
Li, J., Yang, F., Wang, Z., Zheng, S., Zhang, S., Wang, C., He, B., Wang, J. B., & Wang, H. (2024). METTL16 ‐mediated N6 ‐methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer. Cell Proliferation. https://doi.org/10.1111/cpr.13590
Vancouver
Li J, Yang F, Wang Z, Zheng S, Zhang S, Wang C, et al. METTL16 ‐mediated N6 ‐methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer. Cell Proliferation. 2024. doi:10.1111/cpr.13590
BibTeX
@article{Li2024,
author = {Li, Jimin and Yang, Fang and Wang, Zeyu and Zheng, Siqing and Zhang, Shuang and Wang, Chen and He, Bing and Wang, Jia-Bei and Wang, Hao},
title = {METTL16 ‐mediated N6 ‐methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer},
journal = {Cell Proliferation},
year = {2024},
doi = {10.1111/cpr.13590}
}
EUVIMED